Intervacc AB (publ) (STO:IVACC)
1.242
+0.020 (1.64%)
Jul 24, 2026, 4:40 PM CET
Intervacc AB Revenue
Intervacc AB had revenue of 4.23M SEK in the quarter ending March 31, 2026, a decrease of -19.40%. This brings the company's revenue in the last twelve months to 21.27M, up 36.75% year-over-year. In the year 2025, Intervacc AB had annual revenue of 22.28M with 74.13% growth.
Revenue (ttm)
21.27M
Revenue Growth
+36.75%
P/S Ratio
22.05
Revenue / Employee
1.18M
Employees
16
Market Cap
416.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.28M | 9.49M | 74.13% |
| Dec 31, 2024 | 12.80M | 3.03M | 30.97% |
| Dec 31, 2023 | 9.77M | -3.31M | -25.30% |
| Dec 31, 2022 | 13.08M | 1.64M | 14.35% |
| Dec 31, 2021 | 11.44M | 1.65M | 16.87% |
| Dec 31, 2020 | 9.79M | -7.79M | -44.32% |
| Dec 31, 2019 | 17.58M | -21.16M | -54.62% |
| Dec 31, 2018 | 38.73M | -12.11M | -23.83% |
| Dec 31, 2017 | 50.85M | -7.16M | -12.34% |
| Dec 31, 2016 | 58.00M | -6.75M | -10.43% |
| Dec 31, 2015 | 64.76M | -15.45M | -19.26% |
| Dec 31, 2014 | 80.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| Xbrane Biopharma AB | 83.30M |
| Oncopeptides AB | 83.24M |
| Corline Biomedical AB | 10.67M |
| Xspray Pharma AB | 2.47M |
| FluoGuide | 349.42K |
| Infant Bacterial Therapeutics AB | -1.00K |
Intervacc AB News
- 2 months ago - Intervacc AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Intervacc AB (OSTO:IVACC) Q1 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
- 4 months ago - Intervacc AB Slides: FY 2026 - Filings
- 5 months ago - Intervacc AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Intervacc AB Annual report: Q4 2025 - Filings
- 5 months ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Reports Q4 2025 Result - GuruFocus
- 8 months ago - Intervacc AB Transcript: DNB Carnegie Småbolagsdag - Transcripts
- 8 months ago - Intervacc AB Quarterly report: Q3 2025 - Filings